Related Experiment Video
Updated: Jun 15, 2025
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
CDC-Funded HIV Testing Services Outcomes in Ending the HIV Epidemic in the U.S. (EHE) and Non-EHE Jurisdictions, 2021
Deesha Patel1, Mesfin S Mulatu1, Guoshen Wang1
1Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention.
Background:
"Ending the HIV Epidemic in the US" (EHE) focuses on 57 jurisdictions most affected by HIV.
Methods:
Using 2021 data from the National HIV Prevention Program Monitoring and Evaluation system, we calculated distributions of Centers for Disease Control and Prevention-funded HIV tests and HIV testing services outcomes in EHE and non-EHE jurisdictions. We conducted χ2 tests and robust Poisson regression to compare differences in outcomes.
Results:
Of the 1 753 873 tests, a greater proportion was conducted in EHE (65.7%) vs non-EHE (34.3%) jurisdictions (P < .001). A greater number of persons newly diagnosed were in EHE (n = 5861) vs non-EHE (n = 2329) jurisdictions; newly diagnosed positivity was also higher in EHE (0.5%) vs non-EHE (0.4%) jurisdictions (prevalence ratio [PR], 1.31; 95% CI, 1.25-1.38). Among persons newly diagnosed, there were no differences in linkage to care within 30 days in EHE (77.9%) vs non-EHE (77.1%) jurisdictions (PR, 1.01; 95% CI, .95-1.07). The proportion of persons newly diagnosed interviewed for partner services was lower in EHE (69.0%) vs non-EHE (84.8%) jurisdictions (PR, 0.81; 95% CI, .76-.87).
Conclusions:
Centers for Disease Control and Prevention-funded HIV testing services in EHE jurisdictions conducted more HIV testing and diagnosed more persons. Jurisdictions can further expand HIV testing and related services to continue striving toward EHE goals.
